Publications by authors named "David Combarel"

Claim this Profile
M
Melanoma targeted therapies dabrafenib and trametinib cross the placental barrier in ex vivo human placental perfusions.
Estelle Heggarty, David Combarel, Hadia Moindjie, François Vialard, Laure Benoit

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Therapy in a Patient With -Mutated NSCLC Developing Sequential Fusion and V600E Mutation as Bypass Resistance Mechanisms.
Arianna Marinello, Claudia Parisi, Damien Vasseur, David Combarel, Juliette Bihoreau

JTO Clin Res Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plasma concentration and clearance associated with overall survival in patients with renal cell carcinoma.
Christophe Maritaz, David Combarel, Cécile Dalban, Louis Blondel, Sophie Broutin

J Immunother Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Targeted Therapies and Pancreatitis in Patients With Advanced Nonsmall Cell Lung Cancer.
May-Lucie Meyer, Louis Gros, Natalie Décosterd, Marco Tagliamento, Arianna Marinello, David Combarel

Clin Lung Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
Laura Danhardt, Arnaud Wiedemann, Gerard Michel, Jean-Hugues Dalle, Fanny Rialland, David Combarel

EJHaem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies.
Francesco Facchinetti, Yohann Loriot, Floriane Brayé, Damien Vasseur, Rastislav Bahleda, David Combarel

Clin Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Score to Predict the Clinical Usefulness of Therapeutic Drug Monitoring: Application to Oral Molecular Targeted Therapies in Cancer.
Arthur Géraud, David Combarel, Christian Funck-Brentano, Quentin Beaulieu, Noël Zahr

Clin Pharmacol Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: "Therapeutic Drug Monitoring of Oral Oncology Drugs: Another Example of Maslow's Hammer" and "Therapeutic Drug Monitoring of Oral Oncology Drugs: Finding the Right Nails".
David Combarel, Arthur Geraud, Paul Gougis

Clin Pharmacol Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine kinase inhibitors in cancers: Treatment optimization - Part II.
Florent Ferrer, Pauline Tetu, Léa Dousset, Céleste Lebbe, Joseph Ciccolini, David Combarel

Crit Rev Oncol Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine kinase inhibitors in cancers: Treatment optimization - Part I.
David Combarel, Léa Dousset, Stéphane Bouchet, Florent Ferrer, Pauline Tetu

Crit Rev Oncol Hematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Pain Medication in Patients With a History of Bariatric Surgery: A Systematic Review.
Matthieu Delaye, Arthur Geraud, Julia Delahousse, Angelo Paci, Daphné Morel, David Combarel

J Pain Symptom Manage· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer survivors' opinion on personalizing endocrine therapy and developing informative tools.
Elie Rassy, Chiara Benvenuti, Sarra Akla, Antonio Di Meglio, Elise Martin, David Combarel

NPJ Breast Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors.
Laurent Mathiot, David Combarel, Justin Cagnat, Julia Delahousse, Kaissa Ouali

J Immunother Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
Benoit Blanchet, Alexandre Xu-Vuilard, Anne Jouinot, Florent Puisset, David Combarel

Br J Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer.
Francesco Facchinetti, Antoine Hollebecque, Floriane Braye, Damien Vasseur, Yoann Pradat, David Combarel

Cancer Discov· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualizing busulfan dose in specific populations and evaluating the risk of pharmacokinetic drug-drug interactions.
David Combarel, Julie Tran, Julia Delahousse, Gilles Vassal, Angelo Paci

Expert Opin Drug Metab Toxicol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amniotic Aaquaporins (AQP) in Normal and Pathological Pregnancies: Interest in Polyhydramnios.
Jean Guibourdenche, Fideline Bonnet-Serrano, Lila Younes Chaouch, Vincent Sapin, Vassilis Tsatsaris, David Combarel

Reprod Sci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic Analysis of Pazopanib in Patients and Determination of Target AUC.
Agustos Cetin Ozbey, David Combarel, Vianney Poinsignon, Christine Lovera, Esma Saada

Pharmaceuticals (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Concomitant Proton Pump Inhibitor and Cabozantinib on the Outcomes of Patients with Metastatic Renal Cell Carcinoma.
Elie Rassy, Luigi Cerbone, Edouard Auclin, Axelle Benchimoll-Zouari, Ronan Flippot, David Combarel

Oncologist· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung Cancer.
Arthur Geraud, Laura Mezquita, Edouard Auclin, David Combarel, Julia Delahousse

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of serum angiogenic factors with bronchopulmonary dysplasia. The ANGIODYS cohort study.
Héloïse Torchin, David Combarel, Marie-Stéphanie Aubelle, Clémence Lopez, Lauréline Dubray

Pregnancy Hypertens· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Fast Ultra-High Performance Liquid Chromatography-Fluorescent Method for the Quantification of Hydroxychloroquine and Its Metabolites in Patients With Lupus.
Gaëlle Noé, Zahir Amoura, David Combarel, Lesli Lori, Nadine Tissot

Ther Drug Monit· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of Invasive Aspergillus Fungal Infections with the Suspension and Delayed-Release Tablet Formulations of Posaconazole in Patients with Haematologic Malignancies.
Elisabeth Leclerc, David Combarel, Madalina Uzunov, Véronique Leblond, Christian Funck-Brentano

Sci Rep· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis